
For pharmaceuticals is $ 489,000 in federal funds under the Project Discovery therapeutic skills Pro-Pharmaceuticals, Inc., Galectin a developer receiving therapeutic target to treat cancer and fibrosis, today announced that it has been reported to have received approximately $ 489 000 in total two federal grants under the discovery of the therapeutic project qualification (“QTDP”) program.
BREAST CANCER can be cured with Natural Remedies